GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Cefuroxime - oral and injectable source sections

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Oral cefuroxime axetil and injectable cefuroxime sodium are separate formulations. Original source sections are retained, not combined into a single protocol.

The imported UCSF table covers oral cefuroxime axetil only. It is not corroboration of the original page's IV cefuroxime dosing.

The UCSF addition applies only to oral cefuroxime axetil, not injectable cefuroxime sodium. Use the separate injection page for injectable product guidance.

Check source scope before reading a dose

UCSF - oral cefuroxime axetil

Product / population
Adults; oral cefuroxime axetil only.
Renal method
CrCl in mL/min where specified; no equation inferred.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Professional

UCSF - oral cefuroxime axetil

Open original reference

UCSF Infectious Diseases Management Program · Adults; oral cefuroxime axetil only.

Renal method: CrCl in mL/min where specified; no equation inferred.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

Oral cefuroxime axetil: CrCl >30 mL/min, 500 mg twice daily; 10-29, 250 mg twice daily; <10, 250 mg daily. Exactly 30 is not assigned by the displayed ranges.

Intermittent HD: 250 mg orally daily. Continuous-HD dosing is not supplied. This protocol cannot be used for injectable cefuroxime sodium; the separate injection page has its own guidance.

RDM30-049-cefuroxime-1 · Source locator: UCSF - oral cefuroxime axetil; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/cefuroxime-axetil
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min where specified; no equation inferred.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
8fac837ea688207a4c0296265af8134c8a413d8b78c1caafb8979cb949303b8a

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=cefuroxime&s1=RDM30-049-cefuroxime&h1=e8eb1ddb5953bb8b3282ece476127538e7634c8f397c05c0fc4aea52f4d5fd02